Guanxinning tablets improve myocardial hypertrophy by inhibiting the activation of MEK-ERK1/2 signaling pathway
Journal of Applied Biomedicine · 2023
DOI: 10.32725/jab.2023.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Biomedicine, 2023. Verfasst von Yan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314000, China. Hauptthemen laut MEDLINE: MAP Kinase Signaling System, Heart Failure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314000, China.
- Zhejiang Chinese Medical University, Academy of Chinese Medicine & Institute of Comparative Medicine, Hangzhou 310053, China.
- Zhejiang Chinese Medical University, College of Pharmacy, Hangzhou 310053, China.
Zitieren
APA
Zhang, Y., Huang, Y., Ma, Q. X., Xu, S. T., Shen, L., Xu, Y. Y., Hai-Ye, T., Chen, M. L., & Rong, Y. L. (2023). Guanxinning tablets improve myocardial hypertrophy by inhibiting the activation of MEK-ERK1/2 signaling pathway. Journal of Applied Biomedicine. https://doi.org/10.32725/jab.2023.014
Vancouver
Zhang Y, Huang Y, Ma QX, Xu ST, Shen L, Xu YY, et al. Guanxinning tablets improve myocardial hypertrophy by inhibiting the activation of MEK-ERK1/2 signaling pathway. Journal of Applied Biomedicine. 2023. doi:10.32725/jab.2023.014
BibTeX
@article{Zhang2023,
author = {Zhang, Yan and Huang, Yu and Ma, Quan-Xin and Xu, Song-Tao and Shen, Liye and Xu, Yan-Yun and Hai-Ye, Tu and Chen, Min-Li and Rong, Yi-Li},
title = {Guanxinning tablets improve myocardial hypertrophy by inhibiting the activation of MEK-ERK1/2 signaling pathway},
journal = {Journal of Applied Biomedicine},
year = {2023},
doi = {10.32725/jab.2023.014}
}
EUVIMED